Steeg P S
Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Curr Opin Oncol. 1992 Feb;4(1):134-41. doi: 10.1097/00001622-199202000-00018.
Tumor metastasis remains a major cause of death for cancer patients. From a clinical perspective, treatment of metastatic disease remains difficult. The initial tumor cell invasive and locomotive events have been completed in many patients by the time of cancer diagnosis and surgery. This observation focuses attention on the last steps in the metastatic cascade for therapeutic development, ie, angiogenesis and colonization at the metastatic site. Emerging themes in metastasis research, including the molecular characterization of protease production and angiogenesis, the interrelationship of growth and metastasis, and the genetic control of the metastatic process are discussed.
肿瘤转移仍然是癌症患者死亡的主要原因。从临床角度来看,转移性疾病的治疗仍然困难。在许多患者中,在癌症诊断和手术时,最初的肿瘤细胞侵袭和移动事件已经完成。这一观察结果将注意力集中在转移级联反应的最后步骤上,以便进行治疗开发,即转移部位的血管生成和定植。本文讨论了转移研究中的新兴主题,包括蛋白酶产生和血管生成的分子特征、生长与转移的相互关系以及转移过程的遗传控制。